Stockscreener 앱 받기
262.00
1.72%
-4.58
시간 외 거래:
262.00
전일 마감가:
$266.58
열려 있는:
$267.43
하루 거래량:
688.09K
Relative Volume:
1.12
시가총액:
$18.38B
수익:
$1.87B
순이익/손실:
$395.30M
주가수익비율:
153.22
EPS:
1.71
순현금흐름:
$182.40M
1주 성능:
+0.32%
1개월 성능:
+10.79%
6개월 성능:
+43.33%
1년 성능:
+44.50%
1일 변동 폭
$261.92
$267.43
1주일 범위
$257.43
$267.43
52주 변동 폭
$160.19
$279.40
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PODD | 262.00 | 18.38B | 1.87B | 395.30M | 182.40M | 1.71 |
| ABT | 117.26 | 201.11B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 390.14 | 148.40B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 91.50 | 134.72B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 84.74 | 108.57B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 70.38 | 41.51B | 6.60B | 4.16B | 490.10M | 2.34 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
PODDInsulet Corporation Latest Stock News & Market Updates - StockTitan
Brown Capital Management LLC Sells 11,147 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster - Yahoo Finance
Insulet: Superb Business Growth, Starting Valuations Outsized Risk (NASDAQ:PODD) - Seeking Alpha
Segall Bryant & Hamill LLC Has $14.68 Million Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth - Insider Monkey
Insulet Corporation: Significant Opportunities, Significant ThreatsI'm On The Sidelines - Seeking Alpha
Indexes Show More Strength, Pare Losses: Blue Owl, Chewy, Insulet In FocusVideoIBD - Investor's Business Daily
Insulet To Present At Wolfe Research Healthcare Conference; Webcast At 12:00 PM ET - Nasdaq
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More - MSN
Insulet's Omnipod 5 Expands Leadership with FreeStyle Libre 2 Plus Integration | PODD Stock News - StockTitan
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - MSN
15,111 Shares in Insulet Co. (NASDAQ:PODD) Acquired by LMR Partners LLP - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Insulet Corp - Cyber Magazine
Mizuho Securities USA LLC Boosts Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals - Yahoo Finance
GSA Capital Partners LLP Acquires Shares of 4,370 Insulet Co. (NASDAQ:PODD) - MarketBeat
Commit To Buy Insulet At $260, Earn 15.4% Annualized Using Options - Nasdaq
Insulet to Present at Major Healthcare Conferences, Showcasing Omnipod 5 Innovation | PODD Stock News - StockTitan
William Blair Has Optimistic Outlook of Insulet Q3 Earnings - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Principal Financial Group Inc. - MarketBeat
Insulet corp director Luciana Borio sells $139,598 in stock - Investing.com
Insider Sale: Director Luciana Borio Sells Shares of Insulet Cor - GuruFocus.com
Insulet corp director Luciana Borio sells $139,598 in stock By Investing.com - Investing.com UK
William Blair Issues Optimistic Outlook for Insulet Earnings - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Capital Research Global Investors Expands Stake in Insulet Corp - GuruFocus.com
Insulet's SWOT analysis: diabetes tech leader faces competition in pump market - Investing.com
Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace - Yahoo Finance
Insulet Corporation Rings the Closing Bell - Nasdaq
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Acquired by Baillie Gifford & Co. - MarketBeat
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up - Yahoo Finance
Insulet price target raised to $317 from $234 at Morgan Stanley - Yahoo Finance
Barclays raises Insulet stock price target following robust Q3 beat By Investing.com - Investing.com Canada
Barclays raises Insulet stock price target following robust Q3 beat - Investing.com India
Barclays Increases Insulet (NASDAQ:PODD) Price Target to $234.00 - MarketBeat
Morgan Stanley Raises Insulet (NASDAQ:PODD) Price Target to $317.00 - MarketBeat
Insulet Corporation (PODD) PT Raised to $234 at Barclays - StreetInsider.com
Insulet Q3 2024 revenue up 25.7% to USD 543.9M - Medical Buyer
Leerink Partnrs Analysts Cut Earnings Estimates for Insulet - MarketBeat
Ownership Capital B.V. Decreases Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Insulet (NASDAQ:PODD) Shares Up 10.7% After Analyst Upgrade - MarketBeat
Insulet Corporation (NASDAQ:PODD) Q3 2024 Earnings Call Transcript - Insider Monkey
Insulet Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
AEGON ASSET MANAGEMENT UK Plc Has $31.51 Million Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Robeco Institutional Asset Management B.V. Cuts Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Raises Revenue Forecast As Demand For Omnipod Grows - Finimize
Earnings call: Insulet Corporation touts strong Q3 growth and type 2 expansion - Investing.com
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.66%
0.80%
자본화:
|
볼륨(24시간):